Celiac disease: why the gut gets damaged and how it heals

Tissue destruction and healing in Celiac Disease

NIH-funded research University of Chicago · NIH-11159754

Researchers are looking at why some people with celiac disease still have gut damage and symptoms despite a gluten-free diet, to help patients who don't fully recover.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Chicago NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-11159754 on NIH RePORTER

What this research studies

This project will collect small-intestine tissue and clinical data from children and adults with celiac disease to compare those who heal on a gluten-free diet with those who do not. Scientists will study immune cells driving tissue damage, measure nutrient and lipid levels, and analyze the small-intestinal mucosal microbiome. By linking immune, microbial, and metabolic information with biopsy findings, the team aims to explain why healing is inconsistent and why some patients develop complications like bone disease or persistent symptoms. The work combines lab analysis of biopsies with clinical follow-up to identify patterns that could guide future care.

Who could benefit from this research

Good fit: People diagnosed with celiac disease—children and adults—especially those with ongoing symptoms, nutrient deficiencies, or continued intestinal damage despite following a gluten-free diet.

Not a fit: People without celiac disease or whose symptoms are caused by other conditions (for example, irritable bowel syndrome or non-celiac gluten sensitivity) are unlikely to benefit directly.

Why it matters

Potential benefit: If successful, this work could help doctors identify why some patients don't heal and lead to better monitoring or new treatments to prevent complications.

How similar studies have performed: Prior research has linked immune responses and the microbiome to celiac disease, but combining small-intestinal mucosal microbiota, immune profiling, and metabolic data to explain inconsistent healing is a relatively new approach.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Bone DiseasesCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.